Our Services
JSI Research Chemicals is actively involved in pharmaceutical and biotechnology research, particularly in the fields of Alzheimer’s diseases, cancer, and flaviviral diseases. We are a 100% Canadian owned and operated company, and are proud to provide you with our best customer service. We not only do our own research, but also operate as a Contract Research Organization (CRO). This dual capacity allows for a comprehensive approach to drug discovery, development, and testing. Here are key highlights of our services:
1. CRO Services: JSI serves as a CRO, offering a spectrum of research services to pharmaceutical and biotechnology companies. This includes assistance at various stages of drug discovery and development.
2. Consolidated R&D Activities: By offering both innovative research and CRO services, we provide collaborators with the opportunity to consolidate the majority of their R&D activities in one place. By keeping client needs in one place, we can streamline product development, consulting services, communication, enhance collaboration, and simplify project management.
3. Comprehensive Capabilities: JSI’s broad capabilities cover various aspects of drug discovery & development, from initial research and process development to manufacturing. Our comprehensive
approach contributes to efficiency, and seamless transitions between different stages of development.
4. Advanced Technologies: Leveraging advanced technologies is crucial in modern drug discovery & development. JSI’s commitment to incorporating advanced technologies positions us at the forefront of innovation in the pharmaceutical industry.
5. Dedicated Project Managers: The presence of dedicated Project Managers is essential for effective coordination and communication. Having individuals focused on overseeing projects contributes to smoother transitions and faster development timelines.
6. Increased Speed to Patients: By consolidating R&D activities and employing a comprehensive approach, JSI aims to increase the speed at which new drugs can reach patients. We understand that this work is critical, especially in the context of addressing urgent healthcare needs.
JSI’s approach of serving as both an innovative research facility and CRO, along with its emphasis on technology, dedicated project management, and consolidated services, makes it well-positioned to drive momentum in pharmaceutical drug development. Our integrated model results in accelerated timelines and more efficient delivery of new therapies to patients.